Percutaneous Skeletal Fixation of Painful Subchondral Bone Marrow Edema Utilizing an Injectable, Synthetic, Biocompatible Hyaluronic Acid-Based Bone Graft Substitute.
Publication/Presentation Date
11-1-2020
Abstract
Subchondral bone marrow edema (SBME) represents a pathologic alteration of subchondral bone. A strong correlation exists between its presence and the progression of osteoarthritis. Very few treatment options exist between the spectrum of conservative management and the definitive treatment of total knee arthroplasty (TKA). Tactoset® is an injectable synthetic, biocompatible hyaluronic acid-based bone graft substitute that allows for a minimally invasive treatment for painful SBME via percutaneous skeletal fixation (PSF). We present the technique of PSF using Tactoset.
Volume
9
Issue
11
First Page
1645
Last Page
1645
ISSN
2212-6287
Published In/Presented At
Stark, M., DeBernardis, D., McDowell, C., Ford, E., & McMillan, S. (2020). Percutaneous Skeletal Fixation of Painful Subchondral Bone Marrow Edema Utilizing an Injectable, Synthetic, Biocompatible Hyaluronic Acid-Based Bone Graft Substitute. Arthroscopy techniques, 9(11), e1645–e1650. https://doi.org/10.1016/j.eats.2020.07.005
Disciplines
Medicine and Health Sciences
PubMedID
33294321
Department(s)
Department of Surgery
Document Type
Article